SC 13G/AAMENDMENTCUECIK 0001645460

Cue Biopharma, Inc.

Name: SEC EDGAR filing 0001213900-26-107721
Creator: Cue Biopharma, Inc.
License: https://www.usa.gov/government-works

5%+ passive stake (SC 13G/A) filed October 8, 2026.

Short-form disclosure of beneficial ownership above 5% by passive investors with no control intent.

Open the filing on SEC.gov

New to the SC 13G/A? What it is and how to read one

Filing facts

Accession number: 0001213900-26-107721
Filer: Cue Biopharma, Inc.
Ticker: CUE
CIK: 0001645460
Form type: SC 13G/A
Form description: 5%+ passive stake
Filed at: October 8, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 8, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1645460/000121390026107721/0001213900-26-107721-index.htm ↗

Filer's full EDGAR submission history

EDGAR · Cue Biopharma, Inc. (0001645460) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001213900-26-107721.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.